2.52
-0.21 (-7.69%)
-0.21 (-7.69%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 64,199 |
|
|||||
| News | - | ||||||
| Day High | 2.80 | Low High |
|||||
| Day Low | 2.56 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| TransCode Therapeutics Inc | RNAZ | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.21 | -7.69% | 2.52 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.80 | 2.56 | 2.80 | 2.70 | 2.73 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 329 | 64,199 | $ 2.64 | $ 169,550 | - | 2.35 - 7.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:36:59 | formt | 100 | $ 2.52 | USD |
Period:
Draw Mode:
TransCode Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 32.52M | 12.90M | 8.70M | $ - | $ - | -0.32 | -3.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 32.60% |
TransCode Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNAZ Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.68 | 3.10 | 2.56 | 2.74 | 104,678 | -0.16 | -5.97% |
| 1 Month | 3.35 | 3.40 | 2.51 | 2.85 | 88,621 | -0.83 | -24.78% |
| 3 Months | 2.80 | 5.2786 | 2.35 | 3.95 | 4,189,230 | -0.28 | -10.0% |
| 6 Months | 6.00 | 7.00 | 2.35 | 4.07 | 2,919,583 | -3.48 | -58.0% |
| 1 Year | 6.00 | 7.00 | 2.35 | 4.07 | 2,919,583 | -3.48 | -58.0% |
| 3 Years | 6.00 | 7.00 | 2.35 | 4.07 | 2,919,583 | -3.48 | -58.0% |
| 5 Years | 6.00 | 7.00 | 2.35 | 4.07 | 2,919,583 | -3.48 | -58.0% |
TransCode Therapeutics Description
| TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. |
